[HTML][HTML] Use of thrombopoietin receptor agonists in prolonged thrombocytopenia after hematopoietic stem cell transplantation
Prolonged thrombocytopenia after hematopoietic stem cell transplantation (HSCT) is a
strong risk factor for transplantation-related morbidity and mortality, and no standard …
strong risk factor for transplantation-related morbidity and mortality, and no standard …
Thrombocytopenia and therapeutic strategies after allogeneic hematopoietic stem cell transplantation
L Bento, M Canaro, JM Bastida, A Sampol - Journal of Clinical Medicine, 2022 - mdpi.com
Thrombocytopenia following allogeneic hematopoietic stem cell transplantation is a usual
complication and can lead to high morbidity and mortality. New strategies, such as the use of …
complication and can lead to high morbidity and mortality. New strategies, such as the use of …
[HTML][HTML] Thrombopoietin receptor agonists for severe thrombocytopenia after allogeneic stem cell transplantation: experience of the Spanish group of hematopoietic …
L Bento, JM Bastida, I García-Cadenas… - Biology of Blood and …, 2019 - Elsevier
Persistent thrombocytopenia is a common complication after allogeneic hematopoietic stem
cell transplantation (allo-SCT). Romiplostim and eltrombopag are the currently available …
cell transplantation (allo-SCT). Romiplostim and eltrombopag are the currently available …
Eltrombopag is an effective and safe therapy for refractory thrombocytopenia after haploidentical hematopoietic stem cell transplantation
H Fu, X Zhang, T Han, X Mo, Y Wang, H Chen… - Bone Marrow …, 2019 - nature.com
Refractory thrombocytopenia is a frequent and severe complication after haploidentical
allogeneic hematopoietic stem cell transplantation (haplo-HSCT) and lacks effective …
allogeneic hematopoietic stem cell transplantation (haplo-HSCT) and lacks effective …
Avatrombopag for the treatment of thrombocytopenia post hematopoietic stem-cell transplantation
M Zhou, J Qi, C Gu, H Wang, Z Zhang… - Therapeutic …, 2022 - journals.sagepub.com
Background: Thrombocytopenia post hematopoietic stem-cell transplantation (HCT) usually
contributes to poor outcomes with no standardized treatment. Eltrombopag and romiplostim …
contributes to poor outcomes with no standardized treatment. Eltrombopag and romiplostim …
Virus reactivation and low dose of CD34+ cell, rather than haploidentical transplantation, were associated with secondary poor graft function within the first 100 days …
YQ Sun, Y Wang, XH Zhang, LP Xu, KY Liu… - Annals of …, 2019 - Springer
Secondary poor graft function (sPGF) is defined as secondary cytopenia after initial
engraftment of allogeneic stem cell transplantation (allo-SCT). It has been shown to be …
engraftment of allogeneic stem cell transplantation (allo-SCT). It has been shown to be …
Analysis of the efficacy and safety of avatrombopag combined with MSCs for the treatment of thrombocytopenia after allogeneic hematopoietic stem cell …
L Zhu, J Liu, P Kong, S Gao, L Wang, H Liu… - Frontiers in …, 2022 - frontiersin.org
Platelet graft failure (PGF) is a frequent and serious complication after Allogeneic
hematopoietic stem cell transplantation (allo-HSCT) and lacks effective treatment strategies …
hematopoietic stem cell transplantation (allo-HSCT) and lacks effective treatment strategies …
Delayed platelet recovery after allogeneic hematopoietic stem cell transplantation: association with chronic graft‐versus‐host disease and survival outcome
Y Akahoshi, S Kimura, A Gomyo… - Hematological …, 2018 - Wiley Online Library
Delayed platelet recovery (DPR) despite prompt neutrophil engraftment is frequently
observed after allogeneic hematopoietic stem cell transplantation (HSCT). However, few …
observed after allogeneic hematopoietic stem cell transplantation (HSCT). However, few …
[HTML][HTML] Incidence, risk factors, and outcomes of primary prolonged isolated thrombocytopenia after haploidentical hematopoietic stem cell transplant
FF Tang, YQ Sun, XD Mo, M Lv, YH Chen… - Biology of Blood and …, 2020 - Elsevier
The aim of this study was to evaluate the incidence, risk factors, and outcomes of primary
prolonged isolated thrombocytopenia (PT) after haploidentical hematopoietic stem cell …
prolonged isolated thrombocytopenia (PT) after haploidentical hematopoietic stem cell …
[HTML][HTML] Recombinant human thrombopoietin promotes platelet engraftment and improves prognosis of patients with myelodysplastic syndromes and aplastic anemia …
H Wang, M Huang, Y Zhao, JQ Qi, C Chen… - Biology of Blood and …, 2017 - Elsevier
Poor platelet graft function (PPGF) is a significant complication after allogeneic
hematopoietic stem cell transplantation (allo-HSCT). However, no optimal treatment has …
hematopoietic stem cell transplantation (allo-HSCT). However, no optimal treatment has …